Y Intercept (Hong Kong) LTD Dyne Therapeutics, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 80,665 shares of DYN stock, worth $802,616. This represents 0.06% of its overall portfolio holdings.
Number of Shares
80,665
Previous 9,768
725.81%
Holding current value
$802,616
Previous $230,000
266.52%
% of portfolio
0.06%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
218Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Janus Henderson Group PLC London, X010.4MShares$103 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA9.71MShares$96.7 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$90.8 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$73.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$73.5 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $515M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...